SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

David Eric – ‘4’ for 6/27/17 re: Organovo Holdings, Inc.

On:  Thursday, 6/29/17, at 5:13pm ET   ·   For:  6/27/17   ·   Accession #:  1209191-17-42350   ·   File #:  1-35996

Previous ‘4’:  ‘4’ on 5/17/17 for 5/16/17   ·   Next:  ‘4’ on 8/17/17 for 8/16/17   ·   Latest:  ‘4’ on / for 11/16/17

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/29/17  David Eric                        4                      1:5K   Organovo Holdings, Inc.           DONNELLEY FIN… File16/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      3K 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
XML Data rendering:  Form 4 Submission
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0306 </schemaVersion>
<documentType> 4 </documentType>
<periodOfReport> 2017-06-27 </periodOfReport>
<notSubjectToSection16> 0 </notSubjectToSection16>
<issuer>
<issuerCik> 0001497253 </issuerCik>
<issuerName> ORGANOVO HOLDINGS, INC. </issuerName>
<issuerTradingSymbol> ONVO </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001549671 </rptOwnerCik>
<rptOwnerName> David Eric </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> 6275 NANCY RIDGE DRIVE, SUITE 110 </rptOwnerStreet1>
<rptOwnerStreet2></rptOwnerStreet2>
<rptOwnerCity> SAN DIEGO </rptOwnerCity>
<rptOwnerState> CA </rptOwnerState>
<rptOwnerZipCode> 92121 </rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector> 0 </isDirector>
<isOfficer> 1 </isOfficer>
<isTenPercentOwner> 0 </isTenPercentOwner>
<isOther> 0 </isOther>
<officerTitle> CSO & EVP Pre-Clinical Dev </officerTitle>
</reportingOwnerRelationship>
</reportingOwner>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value> Common Stock </value>
<footnoteId id="F1"/>
</securityTitle>
<transactionDate>
<value> 2017-06-27 </value>
</transactionDate>
<deemedExecutionDate></deemedExecutionDate>
<transactionCoding>
<transactionFormType> 4 </transactionFormType>
<transactionCode> A </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
</transactionCoding>
<transactionTimeliness>
<value></value>
</transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value> 190000 </value>
<footnoteId id="F2"/>
</transactionShares>
<transactionPricePerShare>
<value> 0.00 </value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> A </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 890703 </value>
<footnoteId id="F3"/>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<footnotes>
<footnote id="F1"> Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors. </footnote>
<footnote id="F2"> The shares represent a grant of Restricted Stock Units ("RSUs"). The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price. The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2017. </footnote>
<footnote id="F3"> This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David beneficially owns or has a right to acquire 1,960,703 shares of common stock. </footnote>
</footnotes>
<remarks></remarks>
<ownerSignature>
<signatureName> /s/ Eric David </signatureName>
<signatureDate> 2017-06-29 </signatureDate>
</ownerSignature>
</ownershipDocument>


Top
Filing Submission 0001209191-17-042350   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 9:34:41.1pm ET